Oxford-Harrington Rare Disease Centre
@oxfordharrington.bsky.social did:plc:7rm3zq6nutd5zzlv6eiat4dc
Partnership of the University of Oxford and Harrington Discovery Institute. Combining expertise in discovery science and therapeutics development to accelerate cures for rare diseases. Visit us at: www.oxfordharrington.org
No Bluesky desde
- Seguidores
- 108
- Seguindo
- 49
- Posts
- 124
- Dias nos rankings
- 0
Resumo
Oxford-Harrington Rare Disease Centre (@oxfordharrington.bsky.social) é um usuário do Bluesky desde 9 dezembro 2024. Tem 108 seguidores, segue 49 contas e publicou 124 posts.
Aparições nos rankings
Os melhores dias em que posts desta conta entraram na lista diária do Debya.
Esta conta ainda não apareceu em um ranking diário.
Posts curtidos recentemente
Curtidas públicas da rede Bluesky.
The Future for Rare report, published today by @geneticallianceuk.bsky.social, calls for a renewed focus on data, diagnosis, coordinated care, and the appointment of a rare disease lead in each UK country accountable for turning ambition into action. Read now geneticalliance.org.uk/future-for-r...
Ver post🔜 Coming tomorrow across 5 Live Sport, BBC Sounds and BBC Radio Merseyside 🔵 I speak to Everton's Harrison Armstrong about how he really felt when the fans stepped up to stop his sale, becoming David Moyes' Mr Dependable & why his mum keeps him grounded!
Ver post❓ Why do some young people find social interactions less rewarding than others? New research sheds light on the brain mechanisms linked to social #anhedonia - a reduced ability to experience pleasure from social interactions. Read more: tinyurl.com/5n7f39yx @oxfordpsychiatry.bsky.social
Ver postThe 100 days are almost up! Have you signed our petition? Your name could help us drive kidney disease further up the health agenda and transform the future for millions of patients - and it only takes a minute of your time. Add your name here: https://bit.ly/3Wkcl7X Closes Monday 26 October!
Ver postAs an Oxford-Harrington Rare Disease Scholar, Dr. Jacquelyn Bower is developing an AAV gene therapy for uveal melanoma, a rare eye cancer that often leads to blindness. Her approach targets a key mutation driving tumor survival, with potential to extend life and preserve vision.
Ver post
Contas que bloqueia
No Bluesky, bloqueios são registros públicos.
Esta conta não bloqueia ninguém.